(Q42235955)

7

object named as

Gregory Hussey

1 reference

19 October 2017

Roxana Rustomjee

1

1 reference

19 October 2017

Jacqueline Shea

3

1 reference

19 October 2017

P Bernard Fourie

4

1 reference

19 October 2017

Zoë Hindle

5

1 reference

19 October 2017

Gavin Steel

6

1 reference

19 October 2017

Ann Ginsberg

8

1 reference

19 October 2017

Michael J Brennan

Preventive vaccines for tuberculosis

9

1 reference

19 October 2017

8 December 2013

1 reference

19 October 2017

1 reference

19 October 2017

94

1 reference

19 October 2017

178-182

1 reference

19 October 2017

2

1 reference

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

Tuberculosis vaccines: a strategic blueprint for the next decade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

Adaptive licensing: taking the next step in the evolution of drug approval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

Priorities for improving drug research, development and regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

The US Food and Drug Administration provides a pathway for licensing vaccines for global diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

Biomarkers and surrogate markers: an FDA perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

End points and United States Food and Drug Administration approval of oncology drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

Development of new tuberculosis vaccines: a global perspective on regulatory issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

Registering new drugs for low-income countries: the African challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

Regulatory oversight of clinical trials in Africa: progress over the past 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002

A global regulatory science agenda for vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2013.11.002